These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 30974932)

  • 1. Changes in postprandial serum fibroblast growth factor 19 in newly diagnosed type-2 diabetic patients and the clinical significance.
    Zhao L; Cao Y; Liu Y
    J Biol Regul Homeost Agents; 2019; 33(2):385-389. PubMed ID: 30974932
    [No Abstract]   [Full Text] [Related]  

  • 2. Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose.
    Zhang J; Li H; Zhou H; Fang L; Xu J; Yan H; Chen S; Song Q; Zhang Y; Xu A; Fang Q; Ye Y; Jia W
    Sci Rep; 2017 Jul; 7(1):6042. PubMed ID: 28729691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute dietary weight loss on postprandial plasma bile acid responses in obese insulin resistant subjects.
    van Nierop FS; Kulik W; Endert E; Schaap FG; Olde Damink SW; Romijn JA; Soeters MR
    Clin Nutr; 2017 Dec; 36(6):1615-1620. PubMed ID: 27773549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine effects of duodenal-jejunal exclusion in obese patients with type 2 diabetes mellitus.
    Kaválková P; Mráz M; Trachta P; Kloučková J; Cinkajzlová A; Lacinová Z; Haluzíková D; Beneš M; Vlasáková Z; Burda V; Novák D; Petr T; Vítek L; Pelikánová T; Haluzík M
    J Endocrinol; 2016 Oct; 231(1):11-22. PubMed ID: 27474690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes.
    Sonne DP; van Nierop FS; Kulik W; Soeters MR; Vilsbøll T; Knop FK
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3002-9. PubMed ID: 27270475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.
    Borup C; Syversen C; Bouchelouche P; Damgaard M; Graff J; Rumessen JJ; Munck LK
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1399-402. PubMed ID: 26426834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of plasma fibroblast growth factor-21 (FGF-21) in oral glucose tolerance test and effects of metformin on FGF-21 levels in type 2 diabetes mellitus.
    Zhang M; Liu Y; Xiong ZY; Deng ZY; Song HL; An ZM
    Endokrynol Pol; 2013; 64(3):220-4. PubMed ID: 23873427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serum fibroblast growth factor 21 and diabetic nephropathy.
    Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q
    Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y Gastric Bypass Surgery Has Unique Effects on Postprandial FGF21 but Not FGF19 Secretion.
    Harris LLS; Smith GI; Mittendorfer B; Eagon JC; Okunade AL; Patterson BW; Klein S
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3858-3864. PubMed ID: 28938478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Metformin on Fibroblast Growth Factor-21 Levels in Patients with Newly Diagnosed Type 2 Diabetes.
    Fan H; Sun X; Zhang H; Liu J; Zhang P; Xu Y; Pan Q; Wang G
    Diabetes Technol Ther; 2016 Mar; 18(3):120-6. PubMed ID: 26950284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U-shaped relationship between fibroblast growth factor 21 and microvascular complication in type 2 diabetes mellitus.
    Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    J Diabetes Complications; 2017 Jan; 31(1):134-140. PubMed ID: 27839924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations.
    Sánchez-Infantes D; Gallego-Escuredo JM; Díaz M; Aragonés G; Sebastiani G; López-Bermejo A; de Zegher F; Domingo P; Villarroya F; Ibáñez L
    Int J Obes (Lond); 2015 May; 39(5):742-6. PubMed ID: 25599612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.
    Lu J; Yu H; Mo Y; Ma X; Hao Y; Lu W; Li H; Bao Y; Zhou J; Jia W
    PLoS One; 2015; 10(11):e0142207. PubMed ID: 26540514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
    Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
    Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of metformin on fibroblast growth factor 19, 21 and fibroblast growth factor receptor 1 in high-fat diet and streptozotocin induced diabetic rats.
    Wang Y; Dang N; Sun P; Xia J; Zhang C; Pang S
    Endocr J; 2017 May; 64(5):543-552. PubMed ID: 28413172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels.
    Spectre G; Stålesen R; Östenson CG; Hjemdahl P
    Thromb Res; 2016 May; 141():93-7. PubMed ID: 26994470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status.
    Pathak K; Soares MJ; Zhao Y; James AP; Sherriff JL; Newsholme P
    Nutrition; 2017 May; 37():37-42. PubMed ID: 28359360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
    Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
    Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.